Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial

DSpace Repository

Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial

Author: Poeschel, Viola; Held, Gerhard; Ziepert, Marita; Witzens-Harig, Mathias; Holte, Harald; Thurner, Lorenz; Borchmann, Peter; Viardot, Andreas; Soekler, Martin; Keller, Ulrich; Schmidt, Christian; Truemper, Lorenz; Mahlberg, Rolf; Marks, Reinhard; Hoeffkes, Heinz-Gert; Metzner, Bernd; Dierlamm, Judith; Frickhofen, Norbert; Haenel, Mathias; Neubauer, Andreas; Kneba, Michael; Merli, Francesco; Tucci, Alessandra; Brown, Peter de Nully; Federico, Massimo; Lengfelder, Eva; di Rocco, Alice; Trappe, Ralf; Rosenwald, Andreas; Berdel, Christian; Maisenhoelder, Martin; Shpilberg, Ofer; Amam, Josif; Christofyllakis, Konstantinos; Hartmann, Frank; Murawski, Niels; Stilgenbauer, Stephan; Nickelsen, Maike; Wulf, Gerald; Glass, Bertram; Schmitz, Norbert; Altmann, Bettina; Loeffler, Markus; Pfreundschuh, Michael
Tübinger Autor(en):
Sökler, Martin
Published in: Lancet (2019), Bd. 394, H. 10216, S. 2271-2281
Verlagsangabe: Elsevier Science Inc
Language: English
ISSN: 1474-547X
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)